MedBright AI Provides Strategic Update on Investment in Algo8 Industrial AI
VANCOUVER, BRITISH COLUMBIA – September 4, 2025 – MedBright AI Investments Inc. (CSE: MBAI, OTCQB: MBAIF, FSE: Y30) (the “Company” or “MedBright AI”), a capital allocator focused on investing in diversified industries, today provides a strategic update on its investment in Algo8 Industrial AI Inc. (“Algo8”).
The Company’s initial $900,000 investment in March 2025 was a cornerstone of MedBright AI’s strategy to participate in the high-growth industrial AI sector. The investment aimed to accelerate Algo8’s development of next-generation AI solutions designed to drive efficiency, sustainability, and automation in industrial environments.
Since the initial investment, Algo8 has successfully leveraged the capital to expand its technological capabilities and market presence. The company has focused on advancing its core AI technologies, including its “PlantBrain™” platform, which utilizes AI Digital Twins for real-time plant monitoring and predictive maintenance. This progress is a testament to the powerful synergy between MedBright AI’s investment and Algo8’s innovative approach to industrial automation.
“We are incredibly pleased with the progress Algo8 has made since our investment,” said Brandon Kou, Director of MedBright AI. “Their ability to rapidly deploy advanced solutions that directly address the need for smarter, more efficient, and sustainable factories validates our strategic vision. This partnership continues to be a key component of our portfolio, and we are confident in Algo8’s ability to lead the transformation of the industrial sector.”
Nandan Mishra, CEO of Algo8, commented on the development, stating, “The strategic investment from MedBright AI has been instrumental in allowing us to accelerate our product roadmap and expand our reach into new markets. We have made significant strides in advancing our AI-driven solutions for clients, helping them achieve tangible results in terms of operational efficiency and cost savings. We are excited about our continued momentum and the future of our partnership.”
MedBright AI believes that Algo8 is at the forefront of the shift toward autonomous, resilient, and sustainable manufacturing. The Company continues to actively monitor its investment to ensure it aligns with its commitment to generating returns for shareholders by participating in transformative technological opportunities.
The Company also announces that 2 million RSUs have been granted to Brandon Kou vesting immediately. The securities issued are subject to a statutory hold period of 4 months plus a day from the date of issuance in accordance with applicable securities legislation.
About MedBright AI Investments Inc.
MedBright AI Investments Inc. is a capital allocator focused on investing in diversified industries, with a primary focus on technology and artificial intelligence. These include both public and private companies. Medbright has a focus on near-term and mid-term high quality opportunities with strong return potential while maintaining its commitment to governance.
About Algo8 Industrial AI Inc.
Algo8 Industrial AI Inc. is a global pioneer in industrial artificial intelligence, providing intelligent solutions tailored to energy, manufacturing, and asset-heavy industries. Its platform, PlantBrain™, uses advanced AI and machine learning to optimize industrial operations, enabling predictive intelligence, hyper-automation, and sustainable ecosystems.
MedBright AI Investments Inc.
Geoff Balderson, CFO
Email: gb@corporateminds.ca
Phone: (604) 602-0001
www.medbrightai.ca
Forward-Looking Information
This press release contains certain statements that constitute “forward-looking information” within the meaning of applicable securities legislation. All statements other than statements of historical facts, including without limitation, statements regarding the future plans and objectives of the Company and Algo8, the anticipated benefits from the investment in Algo8, and the future performance of Algo8, are forward-looking information. The forward-looking information in this news release is based on a number of assumptions, which may prove to be incorrect.
GoGo Artificial Intelligence Network Inc.
